2016 Product Security Report

For the moment, let’s all breathe a sigh of relief that no major counterfeiting scandal has erupted in the US in the past couple years; although there are always underpublicized cases of drug diversions or the improper purchase of prescription […]

Read More
| 8 Comments

Hub Services Special Report 2016

Market forces are driving pharma manufacturers and patients closer together—and now the pharma industry has a pathway with which to do this. The relationships are growing while pharma contends with regulatory constraints and the competing desires

Read More

The 2015 Biopharma Cold Chain Landscape

Fig. 1. Cold-chain drugs and biologics will outpace overall industry sales growth through 2019 Although dealing with rising cost pressures from payers around the world, the biopharma industry is enjoying strong growth, especially in the US. The long-sought promise of […]

Read More

2015 PDMA Sharing Conference

Back in the day—the year 1990. Heading into the last decade of the 20th century, George H.W. Bush was in office presiding over Operation Desert Storm. The first webpage was written on the World Wide Web. Microsoft released Windows 3.0 […]

Read More

2015 Product Security Report

Fig. 1. Even with a global push for unit serialization via barcodes, there are national variations. The land rush is on. After years of wrangling over compliance requirements for serialization and traceability in the US pharma supply chain, manufacturers and […]

Read More

2015 Hub Services Report

Fig. 1. A view of the relationships and data flows between hubs (lower right) and patient service providers. The ‘Brand Data Center’ essentially resides at the manufacturer. Credit: ProMetrics In 2015, the hub services business model finds itself still struggling […]

Read More